Nephrostomy Devices Market size is set to register considerable growth from 2022 to 2028, owing to a rise in urological conditions and the increasing propensity towards minimally invasive procedures. Nephrostomy devices refer to equipment used to perform nephrostomy, a procedure that involves making an opening between the skin and the kidney. Nephrostomy devices like tubes are thin plastic tubes that are inserted through the skin to the kidney, in order to temporarily drain blocked urine. These devices help improve the functioning of the kidneys, protect them from further harm and also help alleviate infection.
One of the major factors influencing market trends through 2028 includes the rising prevalence of urological conditions across the globe and the subsequent emergence of minimally invasive procedures like percutaneous nephrostomy. This process is gaining increasing favor as a surgical treatment for the decompression of the renal collection system. With this surge in demand for this type of treatment for the growing urological disease burden, the market is expected to amass considerable gains during the forecast period.
With respect to product, the guidewires segment is poised to depict substantial growth through 2028, on account of the minimally invasive nature of the product. Urological guidewires are designed to aid the placement of critical instruments during diagnostic or interventional procedures. Manufacturers are increasingly focusing on developing steerable wires, like JINDO™ Guidewire, that are designed to allow physicians to carry out renal procedures using a single guidewire.
Asia Pacific will emerge as a prominent revenue source for the nephrostomy devices market by 2028, given the rapid expansion of medical tourism in major nations like India. Over the last few years, India has emerged as one of the top destinations for medical tourism across Asia, due to the access to economical healthcare and the presence of super-specialty facilities designed for the treatment of single body systems, such as urology. For instance, the RG Stone Urology and Laparoscopy Hospital is a super specialty hospital in India, that has consolidated quality urological care under one roof. Factors such as these could contribute greatly to the growing demand for nephrostomy devices in the region over the coming years.
Major industry players bolstering the market outlook include Argon Medical, Teleflex, Boston Scientific Corp, Becton, Dickinson and Company, Cardinal Health, B. Braun Melsungen AG, Cook Medical, Olympus Corp, Coloplast Group, and Uresil amongst the others. These companies are involved in various strategic initiatives such as product launches to sustain a strong position in the global market. In August 2021, Argon Medical Devices, Inc. introduced the SKATER™ Mini-Loop Drainage Catheters in the European Union and the United States, as an expansion of the company’s portfolio of SKATER™ All-Purpose and Nephrostomy drainage devices.
Since the onset of the coronavirus outbreak and the subsequent lockdowns announced in March 2020, symptoms of the disease have mainly manifested in the form of respiratory conditions, ranging in severity. In response to this, several facilities, including urology wards were converted into COVID-dedicated facilities, to accommodate the massive surge in COVID-19 patients. Despite setbacks faced by the urology sector due to the suspension of elective and outpatient procedures, however, the nephrostomy devices industry is predicted to gain gradual momentum over the coming years, led by the manifestation of severe genitourinary symptoms in COVID-19 patients. For instance, data from two studies presented at an American Urological Association meeting reported the occurrence of new or worsening overactive bladder symptoms in patients post-recovery, which could amplify demand for nephrostomy drainage devices substantially in the years ahead.
Market, By Product Type
Market, By End-users
The above information is provided for the following regions and countries: